1. Home
  2. BIAF vs CNTM Comparison

BIAF vs CNTM Comparison

Compare BIAF & CNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • CNTM
  • Stock Information
  • Founded
  • BIAF 2014
  • CNTM 2007
  • Country
  • BIAF United States
  • CNTM United States
  • Employees
  • BIAF N/A
  • CNTM N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CNTM
  • Sector
  • BIAF Health Care
  • CNTM
  • Exchange
  • BIAF Nasdaq
  • CNTM NYSE
  • Market Cap
  • BIAF 14.5M
  • CNTM 15.9M
  • IPO Year
  • BIAF 2022
  • CNTM N/A
  • Fundamental
  • Price
  • BIAF $0.99
  • CNTM $1.04
  • Analyst Decision
  • BIAF Strong Buy
  • CNTM
  • Analyst Count
  • BIAF 1
  • CNTM 0
  • Target Price
  • BIAF $6.00
  • CNTM N/A
  • AVG Volume (30 Days)
  • BIAF 148.8K
  • CNTM 180.0K
  • Earning Date
  • BIAF 11-14-2024
  • CNTM 12-16-2024
  • Dividend Yield
  • BIAF N/A
  • CNTM N/A
  • EPS Growth
  • BIAF N/A
  • CNTM N/A
  • EPS
  • BIAF N/A
  • CNTM N/A
  • Revenue
  • BIAF $9,367,785.00
  • CNTM $21,787,239.00
  • Revenue This Year
  • BIAF $285.51
  • CNTM N/A
  • Revenue Next Year
  • BIAF $20.05
  • CNTM N/A
  • P/E Ratio
  • BIAF N/A
  • CNTM N/A
  • Revenue Growth
  • BIAF 2813.87
  • CNTM 12.21
  • 52 Week Low
  • BIAF $0.83
  • CNTM $0.67
  • 52 Week High
  • BIAF $3.62
  • CNTM $12.47
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 41.69
  • CNTM N/A
  • Support Level
  • BIAF $0.83
  • CNTM N/A
  • Resistance Level
  • BIAF $1.04
  • CNTM N/A
  • Average True Range (ATR)
  • BIAF 0.13
  • CNTM 0.00
  • MACD
  • BIAF 0.02
  • CNTM 0.00
  • Stochastic Oscillator
  • BIAF 35.25
  • CNTM 0.00

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About CNTM CONNECTM TECHNOLOGY SOLUTIONS INC

ConnectM Technology Solutions Inc is a clean energy technology and solutions provider. The company provides residential and light commercial buildings and all-electric original equipment manufacturers (OEMs) with a proprietary digital platform to accelerate the transition to solar and all-electric heating, cooling and transportation. The group makes electrification more user-friendly, affordable, precise, and socially meaningful by combining technology, data, artificial intelligence, and contemporary design. In addition to its vertically integrated service network, ConnectM offers customers a comprehensive technology stack that enables them to reduce their fossil fuel consumption, lower their energy bills, and decrease their carbon footprint.

Share on Social Networks: